000			03250nam a2200373 c 4500
988			_aSpringer_BiomedLife_2019
999			_c115562 _d115562 _x1
001			115562
003			ESmaUEC
005			20230110040236.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			190617s2019 ne a o |||| 0|eng d
020			_a9789400777415
024	7		_a10.1007/978-94-007-7741-5 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC669.9 _b2019 EB
245	0	0	_aBiomarkers in Cardiovascular Disease _cedited by Vinood B. Patel, Victor R. Preedy.
264		1	_aDordrecht _bSpringer Netherlands _c2019
300			_a1 recurso en línea (Aproximadamente 800 páginas) _b 50 ilustraciones
336			_aTexto _btxt _2rdacontent
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	0		_aBiomarkers in Disease: Methods Discoveries and Applications _x2542-3657
490	0		_aBiomedical and Life Sciences (Springer-11642)
505	0		_aCardiolog -- Addictions -- Immunology -- Birth Defects -- Genetics.
520	3		_aIn the past decade there has been a major sea change in the way disease is diagnosed and investigated due to the advent of high throughput technologies, such as microarrays, lab on a chip, proteomics, genomics, lipomics, metabolomics etc. These advances have enabled the discovery of new and novel markers of disease relating to autoimmune disorders, cancers, endocrine diseases, genetic disorders, sensory damage, intestinal diseases etc. In many instances these developments have gone hand in hand with the discovery of biomarkers elucidated via traditional or conventional methods, such as histopathology or clinical biochemistry. Together with microprocessor-based data analysis, advanced statistics and bioinformatics these markers have been used to identify individuals with active disease or pathology as well as those who are refractory or have distinguishing pathologies. New analytical methods that have been used to identify markers of disease and is suggested that there may be as many as 40 different platforms. Unfortunately techniques and methods have not been readily transferable to other disease states and sometimes diagnosis still relies on single analytes rather than a cohort of markers. There is thus a demand for a comprehensive and focused evidenced-based text and scientific literature that addresses these issues. Hence the formulation of Biomarkers in Disease. The series covers a wide number of areas including for example, nutrition, cancer, endocrinology, cardiology, addictions, immunology, birth defects, genetics, and so on. The chapters are written by national or international experts and specialists.
650		7	_2embne _aAparato circulatorio _xEnfermedades _9169062
700	1		_aPatel, Vinood B _eeditor _4http://id.loc.gov/vocabulary/relators/edt _985991
700	1		_aPreedy, Victor R _eeditor _4http://id.loc.gov/vocabulary/relators/edt _985990
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-94-007-7741-5 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_aSI _cm _dz _feng _ggw _h0 _b12/2019 _ek _zSI